Accuitis
2011
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Angel
LATEST DEAL TYPE
$1.75M
LATEST DEAL AMOUNT
4
INVESTORS
Description
Developer and marketer of pharmaceuticals for dermatological diseases. The company provides drugs for the treatment of rosacea, which is a dermatological ophthalmic condition.
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
- 4920 Pond Ridge Lane
- Cumming, GA 30041
- United States
+1 (678) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Accuitis’s full profile, request a free trial.
Accuitis Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Angel (individual) | 05-Sep-2017 | $1.75M | 00.000 | Completed | Startup | |
| 1. Grant | Completed | Startup |
Accuitis Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Bio/Med Investor Network | Angel Group | Minority | 000 0000 | 000000 0 | ||
| Georgia Research Alliance | Government | 000 0000 | 000000 0 | |||
| Robert Thomas | Angel (individual) | Minority | 000 0000 | 000000 0 | ||
| GRA Venture Fund | Venture Capital | Minority | 000 0000 | 000000 0 |
Accuitis Executive Team (4)
Accuitis Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Geoffrey Meacham | Bio/Med Investor Network | Board Member | 000 0000 | |
| Michael Shippel | Accuitis | Chief Financial Officer & Board Member | 000 0000 | |
| Robert Thomas Ph.D | Self | Board Member | 000 0000 | |
| Stephen Martin JD | Self | Board Member | 000 0000 |
1 Former Board Member
You’re viewing 4 of 5 board members. Get the full list »